Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Clinical trial NCT03440385 · COMPLETED
Trial details
- NCT number
- NCT03440385
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-07
- Primary completion
- 2023-11-21
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.